Patents by Inventor Silvia Heuerding

Silvia Heuerding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions comprising colloidal silicon dioxide
    Patent number: 8617598
    Abstract: A pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide, wherein the composition comprises 1 to 5% colloidal silicon dioxide by weight.
    Type: Grant
    Filed: June 5, 2012
    Date of Patent: December 31, 2013
    Assignee: Novartis AG
    Inventors: Barbara Haeberlin, Andrea Kramer, Silvia Heuerding
  • Pharmaceutical Compositions Comprising Colloidal Silicon Dioxide
    Publication number: 20120289536
    Abstract: A pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide, wherein the composition comprises 1 to 5% colloidal silicon dioxide by weight.
    Type: Application
    Filed: June 5, 2012
    Publication date: November 15, 2012
    Inventors: Barbara Haeberlin, Andrea Kramer, Silvia Heuerding
  • Organic Compounds
    Publication number: 20120208882
    Abstract: The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).
    Type: Application
    Filed: February 14, 2012
    Publication date: August 16, 2012
    Inventors: Henry Luke Danahay, Darren Mark LeGrand, David C. Tully, Jennifer Leslie Harris, Silvia Heuerding, Dilraj Singh, Janet Catherine Maas, Juergen Roettele, Jean-Louis Reber, Stéphanie Monnier
  • PHARMACEUTICAL COMPOSITIONS COMPRISING COLLOIDAL SILICON DIOXIDE
    Publication number: 20110306630
    Abstract: A pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide, wherein the composition comprises 1 to 5% colloidal silicon dioxide by weight.
    Type: Application
    Filed: June 13, 2011
    Publication date: December 15, 2011
    Inventors: Barbara Haeberlin, Andrea Kramer, Silvia Heuerding
  • PHARMACEUTICAL COMPOSITIONS COMPRISING COLLOIDAL SILICON DIOXIDE
    Publication number: 20100221331
    Abstract: The present invention provides a pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide. The composition comprises 1 to 5% colloidal silicon dioxide by weight.
    Type: Application
    Filed: May 10, 2010
    Publication date: September 2, 2010
    Applicant: NOVARTIS AG
    Inventors: Barbara Haeberlin, Andrea Kramer, Silvia Heuerding
  • ORGANIC COMPOUNDS
    Publication number: 20090203777
    Abstract: The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).
    Type: Application
    Filed: April 12, 2006
    Publication date: August 13, 2009
    Inventors: Henry Luke Danahay, Darren Mark Legrand, David C. Tully, Jennifer Leslie Harris, Silvia Heuerding, Dilraj Singh, Janet Catherine Maas, Juergen Roettele, Jean-Louis Reber, Stephanie Monnier
  • Pharmaceutical compositions comprising colloidal silicon dioxide
    Publication number: 20040254210
    Abstract: A pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide, wherein the composition comprises 1 to 5% colloidal silicon dioxide by weight.
    Type: Application
    Filed: July 30, 2004
    Publication date: December 16, 2004
    Inventors: Barbara Haeberlin, Andrea Kramer, Silvia Heuerding